Direct-to-Consumer Pharmacies Offer Significant Savings on Generic Medications

A study from MD Anderson Cancer Center indicates that direct-to-consumer pharmacy models can substantially decrease out-of-pocket expenses for generic drugs. Analysis showed that patients could save over $100 on higher-cost prescriptions by using these services, with nearly 80% of generic prescriptions becoming cheaper when cost-sharing exceeded $15. This research highlights a promising avenue for improving drug affordability and patient access.